S. Chapet

Randomized Trial of Induction Chemotherapy With Cisplatin and 5-Fluorouracil With or Without Docetaxel for Larynx Preservation

Y. Pointreau, P. Garaud, S. Chapet et al. · JNCI Journal of the National Cancer Institute · 2009 · 569 citations

Medicine, Oncology, Radiation Oncology +12

Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial

J. Guigay, Anne Aupérin, Jérôme Fayette et al. · The Lancet Oncology · 2021 · 232 citations

Medicine, Oncology, Chemotherapy +14

Preoperative radiotherapy (RT) for rectal cancer: Predictive factors of tumor downstaging and residual tumor cell density (RTCD): Prognostic implications

Christine Berger, A. De Muret, P. Garaud et al. · International Journal of Radiation Oncology*Biology*Physics · 1997 · 182 citations

Medicine, Oncology, Surgery +17

Long-Term Results of a Multicenter Randomized Phase III Trial of Induction Chemotherapy With Cisplatin, 5-fluorouracil, ± Docetaxel for Larynx Preservation

G. Janoray, Y. Pointreau, P. Garaud et al. · JNCI Journal of the National Cancer Institute · 2015 · 178 citations · Full text

Medicine, Neck Surgery, Oncology +13

Impact of targeting deviations on outcome in medulloblastoma: study of the French society of pediatric oncology (SFOP)11Participating institutions including more than one patient: Centre Paul Papin—Angers (M. Mege); Bruxelles (C. De Vriendt); Centre Claudius Regaud—Toulouse (F. Soum); Hôpital Charles Nicolle—Rouen (S. Seng); Institut Jean Godinot—Reims (X. Panis); Hôpital Bellevue—Saint-Etienne (T. Schmitt).

C. Carrié, S. Hoffstetter, F. Gómez et al. · International Journal of Radiation Oncology*Biology*Physics · 1999 · 154 citations

Medicine, Oncology, Pediatrics +12